{"preliminary_commentary":{"by_channel":{"x_thread":12,"youtube":2},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT05717166\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"name":"SABR-SYNC","nct_id":"NCT05717166","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=sabr-sync-nct05717166. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 151–300 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"SABR-SYNC","arms":[{"description":"Radiotherapy for patients in the standard arm should follow the principles of palliative radiotherapy as per the individual institution, with the goal of alleviating symptoms or preventing imminent complications.","label":"Standard Arm (Arm 1)","type":"ACTIVE_COMPARATOR"},{"description":"Consists of treatment to the primary tumor and metastases, with SABR preferred, but other options all allowable (e.g. surgery, RFA, fractionated radiation, chemoradiation) if those are deemed to be preferable by the treating oncologists.","label":"Experimental Arm (Arm 2)","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2029-04","type":"ESTIMATED"},"conditions":["Metastatic Tumor"],"enrollment":{"count":180,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Palliative Radiotherapy","otherNames":[],"type":"RADIATION"},{"name":"Chemotherapy","otherNames":["Cytotoxic Systemic Therapy"],"type":"DRUG"},{"name":"Hormone therapy","otherNames":["Hormonal Systemic Therapy"],"type":"DRUG"},{"name":"Immunotherapy","otherNames":[],"type":"DRUG"},{"name":"Targeted Systemic Therapy","otherNames":[],"type":"DRUG"},{"name":"Observation","otherNames":[],"type":"OTHER"},{"name":"Stereotactic Ablative Radiotherapy","otherNames":[],"type":"RADIATION"},{"name":"Surgery","otherNames":[],"type":"PROCEDURE"},{"name":"Radiofrequency Therapy (RFA)","otherNames":[],"type":"OTHER"},{"name":"Fractionated Radiation","otherNames":[],"type":"RADIATION"}],"last_update":"2025-12-31","lead_sponsor":"David Palma","official_title":"A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.","overall_status":"RECRUITING","phases":["PHASE3"],"primary_completion_date":{"date":"2029-04","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Overall Survival","timeFrame":"Approximately end of year 6 (Study Completion)"}],"references":[{"citation":"Palma DA, Giuliani ME, Correa RJM, Schneiders FL, Harrow S, Guckenberger M, Zhang T, Bahig H, Senthi S, Chung P, Olson R, Lock M, Raman S, Bauman GS, Lok BH, Laba JM, Glicksman RM, Nguyen TK, Lang P, Helou J, Goodman CD, Mendez LC, van Rossum PSN, Warner A, Gaede S, Allan AL. A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol. BMC Palliat Care. 2024 Sep 7;23(1):223. doi: 10.1186/s12904-024-01548-7.","pmid":"39244532","type":"DERIVED"}],"start_date":{"date":"2023-10-06","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.","url":"https://clinicaltrials.gov/study/NCT05717166"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/sabr-sync-nct05717166"}